Literature DB >> 12973458

[In vitro activity of azithromycin against clinical isolates of Acinetobacter baumannii].

F Fernández Cuenca1, A Pascual, L Martínez Martínez, E J Perea.   

Abstract

The activity of azithromycin against 225 clinical strains of Acinetobacter baumannii isolated consecutively from 26 Spanish hospitals in November 2000 was studied. The MICs of azithromycin were determined by microdilution, according to the NCCLS guidelines. The bactericidal activity of azithromycin against 15 clonally unrelated A. baumannii strains with different antimicrobial susceptibility patterns was tested using the subculture method. The killing-curves method was also performed against five strains with different susceptibility to azithromycin. The MIC(50) and MIC(90) of azithromycin were 32 and 64 mg/l, respectively. Moderate bactericidal activity was observed in 14 out of the 15 strains evaluated by the subculture method (MBCs from 1 to 4 dilution steps higher than the MICs) and by the killing-curve method. For three strains the number of CFU/ml was reduced 1 to 1.4 log by concentrations of azithromycin equivalent to 1 and 4 times their MICs. lt is concluded that azithromycin has moderate bactericidal activity against the strains of A. baumannii evaluated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973458

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


  3 in total

1.  In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.

Authors:  Seongman Bae; Min-Chul Kim; Su-Jin Park; Hee Sueng Kim; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

2.  Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii.

Authors:  Chandler Roe; Charles H D Williamson; Adam J Vazquez; Kristen Kyger; Michael Valentine; Jolene R Bowers; Paul D Phillips; Veronica Harrison; Elizabeth Driebe; David M Engelthaler; Jason W Sahl
Journal:  Front Public Health       Date:  2020-09-02

3.  Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii.

Authors:  Yu-Shan Cheng; Wei Sun; Miao Xu; Min Shen; Mozna Khraiwesh; Richard J Sciotti; Wei Zheng
Journal:  Front Cell Infect Microbiol       Date:  2019-01-04       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.